Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Riverstone Holdings (AP4) vs. Competitors

25 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
SG:AP4Riverstone HoldingsSGD 0.74SGD 1.07B16.28-14.53%Moderate BuyUnlock the SG:AP4 analyst price target with TipRanks PremiumSG:AP4Unlock the SG:AP4 top-analyst price target with TipRanks Premium
SG:BSLRaffles Medical GroupSGD 0.85SGD 1.58B23.22-15.84%Moderate BuyUnlock the SG:BSL analyst price target with TipRanks PremiumSG:AP4 vs SG:BSLUnlock the SG:BSL top-analyst price target with TipRanks Premium
SG:A50Thomson Medical Group Ltd.SGD 0.05SGD 1.27B-40.27-20.34%Moderate BuyUnlock the SG:A50 analyst price target with TipRanks PremiumSG:AP4 vs SG:A50Unlock the SG:A50 top-analyst price target with TipRanks Premium
SG:1D4Aoxin Q&M Dental Group Ltd.SGD 0.15SGD 177.33M101.33311.11%Moderate BuyUnlock the SG:1D4 analyst price target with TipRanks PremiumSG:AP4 vs SG:1D4Unlock the SG:1D4 top-analyst price target with TipRanks Premium
SG:505Asiamedic LimitedSGD 0.02SGD 21.37M10.00-14.29%―Unlock the SG:505 analyst price target with TipRanks PremiumSG:AP4 vs SG:505Unlock the SG:505 top-analyst price target with TipRanks Premium
SG:5WAOUE Lippo Healthcare LimitedSGD 0.05SGD 217.71M-7.3181.48%―Unlock the SG:5WA analyst price target with TipRanks PremiumSG:AP4 vs SG:5WAUnlock the SG:5WA top-analyst price target with TipRanks Premium

Performance Comparison

-200%0%200%400%600%800%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
SG:AP4Riverstone Holdings0.73-0.13-14.53%
SG:BSLRaffles Medical Group0.85-0.12-12.28%
SG:A50Thomson Medical Group Ltd.0.05-0.01-21.67%
SG:1D4Aoxin Q&M Dental Group Ltd.0.150.11300.00%
SG:505Asiamedic Limited0.02-0.00-10.00%
SG:5WAOUE Lippo Healthcare Limited0.050.0281.48%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts